New restrictions are increasingly squeezing international researchers in the US and threatening the country’s long-term ...

Merck & Co. scientists use a suite of enzymes to manufacture the cholesterol-lowering drug candidate enlicitide ...

In this Eye on Patents column, IP expert Jason Lye explains how China became the global leader in chemistry patents ...

For years, energy has been the Achilles’ heel of the artificial intelligence boom—a technical problem that has steadily become a political one. Soaring demand strains the grid and shows up in ...

Chemical makers express relief after concerns over competitiveness put a stop to the EU’s overhaul of its flagship chemical ...

This Greening Chemistry column explores how to find savings in the lab and the false economy of buying supplies on sale ...

A repurposed reagent can stereoselectively insert nitrogen into C–H bonds, even those unactivated by nearby functional groups ...

Today’s challenges only reinforce Barry Commoner’s call at a 1973 ACS regional meeting to redesign the sector “to accord with ...

These episodes of exhaustion were sometimes so severe that she needed to be hospitalized and receive pain medication and blood transfusions. When she was about 5 years old, the doctors figured out why ...

Woman sits at a desk with a laptop in front of her and is reviewing documents. Meanwhile, a child reaches for the laptop. Mothers working in academia face greater career penalties than fathers in the ...

Attacks on fuel facilities, military bases, and industrial sites release pollutants that might harm long after the war is ...

How reorganizing existing drugs and vaccine components can dramatically alter their potency, selectivity, and even their ...